Cardiac Progenitor Cells in Basic Biology and Regenerative Medicine

الملخص EN

Major cardiovascular events including myocardial infarction (MI) continue to dominate morbidity rates in the developed world.

Although multiple device therapies and various pharmacological agents have been shown to improve patient care and reduce mortality rates, clinicians and researchers alike still lack a true panacea to regenerate damaged cardiac tissue.

Over the previous two to three decades, cardiovascular stem cell therapies have held great promise.

Several stem cell-based approaches have now been shown to improve ventricular function and are documented in preclinical animal models as well as phase I and phase II clinical trials.

More recently, the cardiac progenitor cell has begun to gain momentum as an ideal candidate for stem cell therapy in heart disease.

Here, we will highlight the most recent advances in cardiac stem/progenitor cell biology in regard to both the basics and applied settings.